Citation: | Liu Yanzhong, Bai Hongwei, Qian Yeyong, et al. Summary of treatment experience of carbapenem-resistant Klebsiella pneumoniae infection after renal transplantation in DCD era[J]. ORGAN TRANSPLANTATION, 2020, 11(1): 76-81. doi: 10.3969/j.issn.1674-7445.2020.01.012 |
[1] |
XU L, SUN X, MA X. Systematic review and Meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae[J]. Ann Clin Microbiol Antimicrob, 2017, 16(1):18. DOI: 10.1186/s12941-017-0191-3.
|
[2] |
YIGIT H, QUEENAN AM, ANDERSON GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae[J]. Antimicrob Agents Chemother, 2001, 45(4):1151-1161. doi: 10.1128/AAC.45.4.1151-1161.2001
|
[3] |
范鹏飞, 张玮晔.心脏死亡器官捐献供肝功能维护的研究进展[J/CD].实用器官移植电子杂志, 2016, 4(5): 311-314. DOI: 10.3969/j.issn.2095-5332.2016.05.012.
FAN PF, ZHANG WY. Research progress on the maintenance of liver function from cardiac death organ donation[J/CD]. Pract J Organ Transplant (Electr Vers), 2016, 4(5): 311-314. DOI: 10.3969/j.issn.2095-5332.2016.05.012.
|
[4] |
HU FP, GUO Y, ZHU DM, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014[J]. Clin Microbiol Infect, 2016, 22(Suppl 1):S9-S14. DOI: 10.1016/j.cmi.2016.01.001.
|
[5] |
李智斌, 张更, 刘克普, 等.公民逝世后器官捐献肾移植早期多重耐药菌感染的临床研究[J].器官移植, 2017, 8(5):386-391. DOI: 10.3969/j.issn.1674-7445.2017.05.010.
LI ZB, ZHANG G, LIU KP, et al. Clinical study of early infection of multi-drug resistant organisms after renal transplantation from organ donation after citizen's death[J]. Organ Transplant, 2017, 8(5):386-391. DOI: 10.3969/j.issn.1674-7445.2017.05.010.
|
[6] |
王长希, 邓荣海.公民逝世后器官捐献感染性供者的移植应用[J/CD].中华移植杂志(电子版), 2016, 10(1): 24-28.DOI: 10.3877/cma.j.issn.1674-3903.2016.01.004.
WANG CX, DENG RH. Organ transplantation of infected donors derived from donation after citizen death[J/CD]. Chin J Transplant (Electr Vers), 2016, 10(1): 24-28. DOI: 10.3877/cma.j.issn.1674-3903.2016.01.004.
|
[7] |
许名杰, 谢续标, 彭龙开, 等.肾移植后感染性移植肾动脉破裂五例临床分析[J].中华器官移植杂志, 2017, 38(4):211-217.DOI:10.3760/cma.j.issn.0254-1785. 2017.04.004.
XU MJ, XIE XB, PENG LK, et al. Clinical analysis of 5 cases of infectious renal artery rupture after renal transplantation[J]. Chin J Organ Transplant, 2017, 38(4):211-217. DOI: 10.3760/cma.j.issn.0254-1785.2017.04.004.
|
[8] |
王全楚, 朱晓红, 唐中雷.高致病性肺炎克雷伯杆菌导致的社区获得性肺炎死亡1例[J].中华危重病急救医学, 2017, 29(1):84.DOI:10.3760/cma.j.issn.2095-4352. 2017.01.018.
WANG QC, ZHU XH, TANG ZL. A dead case of severe community-acquired pneumonia caused by highly pathogenic Klebsiella pneumoniae[J]. Chin Crit Care Med, 2017, 29(1):84. DOI:10.3760/cma.j.issn.2095-4352. 2017.01.018.
|
[9] |
韩环立, 张明满, 郭春宝, 等.胆道闭锁患儿肝移植术后并发症分析[J].临床肝胆病杂志, 2017, 33(2):316-319. DOI: 10.3969/j.issn.1001-5256.2017.02.024.
HAN HL, ZHANG MM, GUO CB, et al. An analysisof postoperative complications in children with biliaryatresia after liver transplantation[J]. J Clin Hepatol, 2017, 33(2):316-319. DOI: 10.3969/j.issn.1001-5256.2017.02.024.
|
[10] |
LEWIS JD, SIFRI CD. Multidrug-resistant bacterial donor-derived infections in solid organ transplantation[J]. Curr Infect Dis Rep, 2016, 18(6):18. DOI: 10.1007/s11908-016-0526-9.
|
[11] |
张鹏亮, 徐修礼, 白露.医院感染大肠埃希菌及肺炎克雷伯菌的产酶率与耐药性分析[J].中华医院感染学杂志, 2015, 23(3):508-510.DOI: 10.11816/cn.ni.2015-124964.
ZHANG PL, XU XL, BAI L. Analysis of drug resistance and enzyme production rate of Escherichia coli and Klebsiella pneumoniae in hospital infections[J]. ChinJ Nosocom, 2015, 23(3):508-510. DOI: 10.11816/cn.ni.2015-124964.
|
[12] |
李凤林, 马振广, 夏红强.肺炎克雷伯杆菌致血流感染1例分析[J].实用检验医师杂志, 2016, 8(3):188-190. DOI: 10.3969/j.issn.1674-7151.2016.03.019.
LI FL, MA ZG, XIA HQ. Analysis of 1 case of bloodstream infection caused by Klebsiella pneumoniae[J]. Chin JLabor Path, 2016, 8(3):188-190. DOI: 10.3969/j.issn.1674-7151.2016.03.019.
|
[13] |
TAMINATO M, FRAM D, PEREIRA RRF, et al. Infection related to Klebsiella pneumoniae producing carbapenemase in renal transplant patients[J]. Rev Bras Enferm, 2019, 72(3):760-766. DOI: 10.1590/0034-7167-2019-0009.
|
[14] |
BERGAMASCO MD, BARROSO BARBOSA M, DE OLIVEIRA GARCIA D, et al. Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation[J]. Transpl Infect Dis, 2012, 14(2):198-205. DOI: 10.1111/j.1399-3062.2011.00688.x.
|
[15] |
唐小红, 朱卫民.肺炎克雷伯菌耐碳青霉烯类抗菌药的研究进展[J].国外医药(抗生素分册), 2014, 35(3):115-118, 122.DOI: 10.3969/j.issn.1001-8751.2014.03.004.
TANG XH, ZHU WM. Progress about carbapenem resistant of Klebsiella pneumoniae[J]. World Not Antibio, 2014, 35(3):115-118, 122.DOI:10.3969/j.issn. 1001-8751.2014.03.004.
|
[16] |
HIRSCH EB, TAM VH. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection[J]. J Antimicrob Chemother, 2010, 65(6):1119-1125. DOI: 10.1093/jac/dkq108.
|
[17] |
CICORA F, MOS F, ROBERTI J. Kidney transplant recipients infected with blaKPC-2-producing Klebsiella pneumoniae[J]. Nefrologia, 2015, 35(3):340-343. DOI: 10.1016/j.nefro.2015.02.002.
|
[18] |
DENG M, ZHU MH, LI JJ, et al. Molecular epidemiology and mechanisms of tigecycline resistance in clinical isolates of acinetobacter baumannii from a Chinese university hospital[J]. Antimicrob Agents Chemother, 2014, 58(1):297-303. DOI: 10.1128/AAC.01727-13.
|
[19] |
SPANU T, DE ANGELIS G, CIPRIANI M, et al. In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli[J]. Antimicrob Agents Chemother, 2012, 56(8):4516-4518. DOI: 10.1128/AAC.00234-12.
|
[20] |
LEVASSEUR P, GIRARD AM, CLAUDON M, et al. In vitro antibacterial activity of the ceftazidime-avibactam (NXL104) combination against Pseudomonas aeruginosa clinical isolates[J]. Antimicrob Agents Chemother, 2012, 56(3):1606-1608. DOI: 10.1128/AAC.06064-11.
|
[21] |
曾志旋, 曹胜华, 陈林.新型β-内酰胺酶抑制剂——阿维巴坦的研究进展[J].国外医药(抗生素分册), 2014, 35(2):58-62.DOI: 10.3969/j.issn.1001-8751.2014.02.002.
ZENG ZX, CAO SH, CHEN L. The research advance of a novel β-lactamase inhibitor—avibactam[J]. World Not Antibio, 2014, 35(2):58-62. DOI:10.3969/j.issn.1001- 8751.2014.02.002.
|
[22] |
LAGACÉ-WIENS P, WALKTY A, KARLOWSKY JA. Ceftazidime-avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections[J]. Core Evid, 2014, 9:13-25. DOI: 10.2147/CE.S40698.
|
[23] |
CASTANHEIRA M, MENDES RE, SADER HS. Low frequency of ceftazidime-avibactam resistance among enterobacteriaceae isolates carrying blaKPC collected in U.S. hospitals from 2012 to 2015[J]. Antimicrob Agents Chemother, 2017, 61(3): e02369-16. DOI: 10.1128/AAC. 02369-16.
|
[24] |
YANG M, GAO H, WANG X, et al. Tigecycline treatment in a liver transplant infant with carbapenem-resistant Escherichia coli infection: case report[J]. Medicine (Baltimore), 2019, 98(39):e17339. DOI: 10.1097/MD.0000000000017339.
|